ALX Oncology Holdings Inc
ALXONasdaqCIK 1810182HealthcareFiscal year ends Dec 31
Reports and events: 107 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1601:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-004485 |
| 2026-10-1520:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-422992 |
| 2026-08-0620:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-337920 |
| 2026-08-0612:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336843 |
| 2026-06-3020:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-290447 |
| 2026-06-2620:02 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-285425 |
| 2026-06-1120:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267472 |
| 2026-05-2720:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001643828-26-000002 |
| 2026-05-0812:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213399 |
| 2026-05-0812:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213380 |
| 2026-04-2020:05 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001193125-26-163936 |
| 2026-04-1312:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-152050 |
| 2026-03-0920:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-098454 |
| 2026-02-2713:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-079342 |
| 2026-02-0402:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-000512 |
| 2026-01-3013:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-030579 |
| 2026-01-3013:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-030561 |
| 2026-01-2121:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-018094 |
| 2025-11-0721:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272281 |
| 2025-11-0713:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-271112 |
| 2025-09-1212:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001810182-25-000006 |
| 2025-08-1220:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107303 |
| 2025-08-1220:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107277 |
| 2025-06-1220:18 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-085364 |
| 2025-05-0820:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066894 |
| 2025-05-0812:35 ET | 8-K | 2.02 Results of operations | 0000950170-25-066440 |
| 2025-04-2520:01 ET | 8-K | 3.01 Delisting notice | 0000950170-25-058687 |
| 2025-04-2120:10 ET | DEF 14A | Proxy statementPeriod 2025-04-21 | 0000950170-25-056291 |
| 2025-03-0621:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034761 |
| 2025-03-0621:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034574 |
| 2025-03-0521:01 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0000950170-25-033504 |
| 2025-01-2213:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-007532 |
| 2025-01-1721:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-008461 |
| 2024-11-1413:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-126749 |
| 2024-11-0721:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123290 |
| 2024-11-0721:03 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-123252 |
| 2024-10-0413:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-112734 |
| 2024-08-1220:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095391 |
| 2024-08-0820:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093930 |
| 2024-08-0620:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-091938 |
| 2024-06-1720:21 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-074258 |
| 2024-05-0920:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056953 |
| 2024-05-0920:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056886 |
| 2024-05-0220:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-052093 |
| 2024-04-2220:01 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0000950170-24-046410 |
| 2024-03-0721:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-027955 |
| 2024-03-0721:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-027925 |
| 2024-02-1400:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-024164 |
| 2023-12-2621:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-073016 |
| 2023-12-2022:38 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-127396 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.